Opus Genetics IRD Other
Other at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.
The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opus Genetics's other?
- Opus Genetics (IRD) reported other of -$0 in Q4 2025.
- How has Opus Genetics's other changed year-over-year?
- Opus Genetics's other decreased by 166.7% year-over-year, from $0 to -$0.
- What is the long-term trend for Opus Genetics's other?
- Over 4 years (2021 to 2025), Opus Genetics's other has grown at a 41.4% compound annual growth rate (CAGR), from -$0 to -$0.01.